A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder

2012/04/12 by Eduard Vieta, Stuart Montgomery, Ahmad Hatim Sulaiman +7 · 1 citation
Medicine · #Bipolar Disorder and Treatment #Schizophrenia research and treatment #Treatment of Major Depression

paper · doi:10.1016/j.euroneuro.2012.03.004

openalex publication_date 2012/04/12 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Citations

• Risperidone Safety and Efficacy in the Treatment of Bipolar and Schizoaffective Disorders

Cited by

• Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder
• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder